Literature DB >> 9135144

NIK is a new Ste20-related kinase that binds NCK and MEKK1 and activates the SAPK/JNK cascade via a conserved regulatory domain.

Y C Su1, J Han, S Xu, M Cobb, E Y Skolnik.   

Abstract

Nck, an adaptor protein composed of one SH2 and three SH3 domains, is a common target for a variety of cell surface receptors. We have identified a novel mammalian serine/threonine kinase that interacts with the SH3 domains of Nck, termed Nck Interacting Kinase (NIK). This kinase is most homologous to the Sterile 20 (Ste20) family of protein kinases. Of the members of this family, GCK and MSST1 are most similar to NIK in that they bind neither Cdc42 nor Rac and contain an N-terminal kinase domain with a putative C-terminal regulatory domain. Transient overexpression of NIK specifically activates the stress-activated protein kinase (SAPK) pathway. Both the kinase domain and C-terminal regulatory region of NIK are required for full activation of SAPK. NIK likely functions upstream of MEKK1 to activate this pathway; a dominant-negative MEK kinase 1 (MEKK1) blocks activation of SAPK by NIK. MEKK1 and NIK also associate in cells and this interaction is mediated by regulatory domains on both proteins. Two other members of this kinase family, GCK and HPK1, contain C-terminal regulatory domains with homology to that of NIK. These findings indicate that the C-terminal domain of these proteins encodes a new protein domain family and suggests that this domain couples these kinases to the SAPK pathway, possibly by interacting with MEKK1 or related kinases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135144      PMCID: PMC1169726          DOI: 10.1093/emboj/16.6.1279

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  36 in total

Review 1.  Protein modules and signalling networks.

Authors:  T Pawson
Journal:  Nature       Date:  1995-02-16       Impact factor: 49.962

Review 2.  How MAP kinases are regulated.

Authors:  M H Cobb; E J Goldsmith
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

3.  Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins.

Authors:  M Tanaka; R Gupta; B J Mayer
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

4.  Binding of NCK to SOS and activation of ras-dependent gene expression.

Authors:  Q Hu; D Milfay; L T Williams
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

Review 5.  Modular binding domains in signal transduction proteins.

Authors:  G B Cohen; R Ren; D Baltimore
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

6.  A novel ligand for SH3 domains. The Nck adaptor protein binds to a serine/threonine kinase via an SH3 domain.

Authors:  M M Chou; H Hanafusa
Journal:  J Biol Chem       Date:  1995-03-31       Impact factor: 5.157

7.  Transcription factor ATF2 regulation by the JNK signal transduction pathway.

Authors:  S Gupta; D Campbell; B Dérijard; R J Davis
Journal:  Science       Date:  1995-01-20       Impact factor: 47.728

8.  Cloning and characterization of a human protein kinase with homology to Ste20.

Authors:  C L Creasy; J Chernoff
Journal:  J Biol Chem       Date:  1995-09-15       Impact factor: 5.157

9.  Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains.

Authors:  O M Rivero-Lezcano; A Marcilla; J H Sameshima; K C Robbins
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

10.  Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation.

Authors:  S Bagrodia; B Dérijard; R J Davis; R A Cerione
Journal:  J Biol Chem       Date:  1995-11-24       Impact factor: 5.157

View more
  75 in total

1.  Nckbeta adapter regulates actin polymerization in NIH 3T3 fibroblasts in response to platelet-derived growth factor bb.

Authors:  M Chen; H She; A Kim; D T Woodley; W Li
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Activation of the c-Jun N-terminal kinase pathway by a novel protein kinase related to human germinal center kinase.

Authors:  K Diener; X S Wang; C Chen; C F Meyer; G Keesler; M Zukowski; T H Tan; Z Yao
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

Review 3.  Microarray technology and its application on nicotine research.

Authors:  Ming D Li; Ozien Konu; Justin K Kane; Kevin G Becker
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

4.  Differential tumorigenic potential and matriptase activation between PDGF B versus PDGF D in prostate cancer.

Authors:  Abdo J Najy; Joshua J Won; Lisa S Movilla; Hyeong-Reh C Kim
Journal:  Mol Cancer Res       Date:  2012-06-11       Impact factor: 5.852

Review 5.  Signaling of neuronal cell death by the p75NTR neurotrophin receptor.

Authors:  E J Coulson; K Reid; P F Bartlett
Journal:  Mol Neurobiol       Date:  1999-08       Impact factor: 5.590

6.  MUC1 oncoprotein functions in activation of fibroblast growth factor receptor signaling.

Authors:  Jian Ren; Deepak Raina; Wen Chen; Guilan Li; Lei Huang; Donald Kufe
Journal:  Mol Cancer Res       Date:  2006-11       Impact factor: 5.852

Review 7.  The ERK cascade: a prototype of MAPK signaling.

Authors:  Hadara Rubinfeld; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

8.  Evidence for a role of mixed lineage kinases in neuronal apoptosis.

Authors:  M Mota; M Reeder; J Chernoff; C E Bazenet
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

Review 9.  The Na+/H+ exchanger NHE1 in stress-induced signal transduction: implications for cell proliferation and cell death.

Authors:  Stine Falsig Pedersen
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

10.  Enhancement of lipopolysaccharide-stimulated JNK activity in rat aortic smooth muscle cells by pharmacological and adenovirus-mediated inhibition of inhibitory kappa B kinase signalling.

Authors:  Christopher J MacKenzie; Andrew Paul; Susan Wilson; Rainer de Martin; Andrew H Baker; Robin Plevin
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.